{
    "configs": {
        "calculate": "CALCULATE",
        "stage": "stage",
        "about": "ABOUT",
        "toast_error": "You have to select one option per question",
        "results": "RESULTS"
    },
    "data": {
        "test": {
            "wifi": {
                "name": "WIFI",
                "results": {
                    "1": "Very low risk of amputation.",
                    "2": "Low risk of amputation.",
                    "3": "Moderate risk of amputation.",
                    "4": "High risk of amputation."
                },
                "questions": {
                    "w": {
                        "name": "W",
                        "answers": {
                            "0": "No ulcer and gangrene",
                            "1": "Small, shallow ulcer, minor devitalized tissue.",
                            "2": "Deep ulcer with limited osteotendinous exposure and gangrene.",
                            "3": "Extensive deep ulcer with full exposure, extensive gangrene."
                        }
                    },
                    "i": {
                        "name": "I",
                        "answers": {
                            "0": "ABI˃ 0.8/ASP ˃100 mm Hg /TP, TcPO2 ˃60 mm Hg",
                            "1": "ABI 0.6-0.8/ASP 70-100 mm Hg/ TP, TcPO2 40-60 mm Hg",
                            "2": "ABI 0.4-0.6/ASP 50-70 mm Hg/ TP, TcPO2 30-40 mm Hg",
                            "3": "ABI <0.4/ASP ˂50 mm Hg/ TP, TcPO2 ˂30 mm Hg"
                        },
                        "legends": {
                            "0": {
                                "name": "ABI",
                                "content": "Ankle-brachial index"
                            },
                            "1": {
                                "name": "ASP",
                                "content": "Ankle systolic pressure"
                            },
                            "2": {
                                "name": "TP",
                                "content": "Toe pressure"
                            },
                            "3": {
                                "name": "TcPO2",
                                "content": "Transcutaneous oximetry"
                            }
                        }
                    },
                    "fi": {
                        "name": "FI",
                        "answers": {
                            "0": "No symptoms or signs of infection.",
                            "1": "Superficial localized infection, 2 cm erythema, No SIRS.",
                            "2": "Deep localized infection, 2 cm erythema, No SIRS.",
                            "3": "Extensive infection, SIRS."
                        },
                        "legends": {
                            "0": {
                                "name": "SIRS",
                                "content": "Systemic inflammatory response syndrome."
                            }
                        }
                    }
                }
            },
            "glass": {
                "name": "GLASS",
                "results": {
                    "0": "NA",
                    "1": "Vascular intervention with estimated technical failure <10%",
                    "2": "Vascular intervention with estimated technical failure <20%",
                    "3": "Vascular intervention with estimated technical failure >20%"
                },
                "questions": {
                    "fp": {
                        "name": "Femoropopliteal (FP)",
                        "answers": {
                            "0": "Mild and non-significant disease (<50%).",
                            "1": "Significant lesion in SFA ˂ 10 cm or CTO ˂ 5 cm / Poplitea with non-significant lesions.",
                            "2": "Significant lesion in SFA 10-20 cm or CTO ˂ 10 cm / Poplitea with significant lesions ˂ 2 cm.",
                            "3": "Significant lesion in SFA ˃ 20 cm or CTO 10-20 cm / Popliteal with significant lesions 2-5 cm",
                            "4": "Significant lesion in SFA 20 cm or CTO ˃20 cm / Poplitea with significant lesions ˃ 5 cm that compromise trifurcation."
                        },
                        "legends": {
                            "0": {
                                "name": "SFA",
                                "content": "Superficial femoral artery"
                            },
                            "1": {
                                "name": "CTO",
                                "content": "Chronic total occlusion"
                            }
                        }
                    },
                    "ip": {
                        "name": "Infrapopliteal (IP)",
                        "answers": {
                            "0": "Mild and non-significant disease (<50%).",
                            "1": "Tibial artery injury ˂ 3 cm.",
                            "2": "Diffuse disease involving 1/3 of the vessel, CTO ˂ 3 cm.",
                            "3": "Diffuse disease involving 2/3 of the vessel, CTO 1/3 of the vessel.",
                            "4": "Diffuse disease involving 2/3 of the vessel, CTO 1/3 of the vessel, involvement of the tibioperoneal trunk."
                        }
                    }
                }
            }
        },
        "results": {
            "1": "Not applicable",
            "2": "Endovascular revascularization",
            "3": "Open revascularization (Bypass)",
            "4": "Indeterminate handling, subject to discussion."
        },
        "about": {
            "0": "Wildor Samir Cubas Llalle MD.",
            "1": "Nils Edy Paredes Sánchez",
            "2": "Vascular and Endovascular Surgery Service",
            "3": "Department of Thorax and Cardiovascular Surgery",
            "4": "Edgardo Rebagliati Martins National Hospital. Lima-Peru.",
            "5": "Peruvian Association of Angiology Vascular and Endovascular Surgery (PAAVES)",
            "6": "Algorithm taken and adapted from Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia-2019"
        }
    }
}